Literature DB >> 24820027

Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.

Rika Nishikawa1, Yusuke Goto1, Satoko Kojima2, Hideki Enokida3, Takeshi Chiyomaru3, Takashi Kinoshita1, Shinichi Sakamoto4, Miki Fuse4, Masayuki Nakagawa3, Yukio Naya2, Tomohiko Ichikawa4, Naohiko Seki1.   

Abstract

Our recent studies of microRNA (miRNA) expression signatures revealed that microRNA-29s (miR-29s; including miR-29a/b/c) were significantly downregulated in prostate cancer (PCa) and was a putative tumor-suppressive miRNA family in PCa. Herein, we aimed to investigate the functional significance of miR-29 in cancer cells and to identify novel miR-29s-mediated cancer pathways and target genes involved in PCa oncogenesis and metastasis. Restoration of miR-29s in PC3 and DU145 cell lines revealed significant inhibition of cancer cell migration and invasion. To identify miR-29s-mediated molecular pathways and targets, we used gene expression data and in silico database analysis. Our analysis demonstrated that miR-29s modulated the focal adhesion pathway. Moreover, the laminin γ1 (LAMC1) gene was a candidate target of miR-29s regulation. Luciferase reporter assays showed that miR-29s directly regulated LAMC1. Silencing of LAMC1 significantly inhibited cell migration and invasion in cancer cells, and LAMC1 was upregulated in PCa. miR-29s acted as tumor suppressors, contributing to cancer cell migration and invasion and directly targeting laminin signaling. Recognition of tumor-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of PCa oncogenesis and metastasis, and suggests novel therapeutic strategies for treating this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820027     DOI: 10.3892/ijo.2014.2437

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  58 in total

1.  Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Authors:  Mayuko Kato; Akira Kurozumi; Yusuke Goto; Ryosuke Matsushita; Atsushi Okato; Rika Nishikawa; Ichiro Fukumoto; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

2.  miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Authors:  Rui Li; Jia Liu; Qun Li; Guang Chen; Xiaofang Yu
Journal:  Tumour Biol       Date:  2015-10-19

Review 3.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

4.  Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.

Authors:  Kazuto Kamikawaji; Naohiko Seki; Masaki Watanabe; Hiroko Mataki; Tomohiro Kumamoto; Koichiro Takagi; Keiko Mizuno; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

5.  Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix.

Authors:  John J Wallbillich; Paul Mh Tran; Shan Bai; Lynn Kh Tran; Ashok K Sharma; Sharad A Ghamande; Jin-Xiong She
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 6.166

6.  Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer.

Authors:  X-L Lai; Y-H Huang; Y-S Li; G-N Li; L-P Wang; R Sun; Y-S Ma; S-Y Feng; Z-Y Chang; X-H Wang; D Fu; X Han; X-L Cong; W-P Li
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

7.  miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.

Authors:  Lorenza Pasqualini; Huajie Bu; Martin Puhr; Narisu Narisu; Johannes Rainer; Bettina Schlick; Georg Schäfer; Mihaela Angelova; Zlatko Trajanoski; Stefan T Börno; Michal R Schweiger; Christian Fuchsberger; Helmut Klocker
Journal:  Mol Endocrinol       Date:  2015-06-08

8.  Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.

Authors:  Oh Kwang Kwon; Ju Mi Jeon; Eunji Sung; Ann-Yea Na; Sun Joo Kim; Sangkyu Lee
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

9.  miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.

Authors:  Lingyin Ge; David M Habiel; Phil M Hansbro; Richard Y Kim; Sina A Gharib; Jeffery D Edelman; Melanie Königshoff; Tanyalak Parimon; Rena Brauer; Ying Huang; Jenieke Allen; Dianhua Jiang; Adrianne A Kurkciyan; Takako Mizuno; Barry R Stripp; Paul W Noble; Cory M Hogaboam; Peter Chen
Journal:  JCI Insight       Date:  2016-12-08

10.  MicroRNA-29 family inhibits rhabdomyosarcoma formation and progression by regulating GEFT function.

Authors:  Yang Wang; Liang Zhang; Yuweng Pang; Lingxie Song; Hao Shang; Zhenzhen Li; Qianqian Liu; Yangyang Zhang; Xiaomeng Wang; Qianru Li; Qiaochu Zhang; Chunxia Liu; Feng Li
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.